Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centers Financing will support the development of a dual-incretin-NMDA receptor antagonist conjugate through...
Read More Details
Finally We wish PressBee provided you with enough information of ( Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment )
Also on site :